Check this movie to learn how TRANSVAC2 can support your vaccine development:
TRANSVAC is an infrastructure project that aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges with the ultimate goal to build an efficient and sustainable collaboration of experts and facilities to catalyse vaccine research in Europe. High-quality technical services across different service platforms are offered to support the development of prophylactic and therapeutic vaccines for both human and animal use. TRANSVAC2 is further accelerating vaccine development by applying and improving cutting-edge technologies to address critical issues in modern vaccine development. Additionally, TRANSVAC2 is offering training activities to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics. This project receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 730964.